Get started
Author

Lisanne L. Krens

Observed names: L. Krens, L. L. Krens, L.L. Krens, Lisanne Krens
Institution: Maasstad Ziekenhuis
ORCID: 0000-0003-3842-9585
Observed ORCID: 0000-0003-3842-9585
OpenAlex ID: A5060745655
Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review
2011 · Jara M. Baas, Lisanne L. Krens, et al. · The Oncologist · 89
PDF
Recommendations on management of EGFR inhibitor-induced skin toxicity: A systematic review
2011 · J.M. Baas, L.L. Krens, et al. · Cancer Treatment Reviews · 69
Statin Use Is Not Associated with Improved Progression Free Survival in Cetuximab Treated KRAS Mutant Metastatic Colorectal Cancer Patients: Results from the CAIRO2 Study
2014 · Lisanne L. Krens, Lieke H. J. Simkens, et al. · PLoS ONE · 47
Therapeutic modulation of k-ras signaling in colorectal cancer
2010 · Lisanne L. Krens, Jara M. Baas, et al. · Drug Discovery Today · 47
Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients
2015 · J. M. Baas, L. L. Krens, et al. · Investigational New Drugs · 38
PDF
Assessment of Contraceptive Counseling and Contraceptive Use in Women After Bariatric Surgery
2019 · Michiel A. Damhof, Esther Pierik, et al. · Obesity Surgery · 21
PDF
Safety and efficacy of the addition of simvastatin to panitumumab in previously treated KRAS mutant metastatic colorectal cancer patients
2015 · Jara M. Baas, Lisanne L. Krens, et al. · Anti-Cancer Drugs · 19
Pharmacokinetics and safety of cetuximab in a patient with renal dysfunction
2014 · L. L. Krens, J. M. Baas, et al. · Cancer Chemotherapy and Pharmacology · 14
PDF
Pharmacokinetics of panitumumab in a patient with liver dysfunction: a case report
2013 · L. L. Krens, J. M. Baas, et al. · Cancer Chemotherapy and Pharmacology · 11
Pharmacokinetics and safety of panitumumab in a patient with chronic kidney disease
2017 · L. L. Krens, J. M. Baas, et al. · Cancer Chemotherapy and Pharmacology · 10
PDF
Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab
2018 · Jara Baas, Lisanne Krens, et al. · PLoS ONE · 8
PDF
Evaluation and validation of a clinical decision support system for dose optimisation in hospitalized patients with (morbid) obesity – a retrospective, observational study
2025 · Lianne Brand, L. Mitrov-Winkelmolen, et al. · BMC Medical Informatics and Decision Making · 3
Pharmacogenomics-guided personalized medicine in a clinical setting: real-world data
2025 · Jiayi Liang, Lianne Brand, et al. · Pharmacogenetics and Genomics · 2
The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study
2025 · Mart P. Kicken, Rob ter Heine, et al. · Clinical Lung Cancer · 2
PDF
Evaluation of a clinical decision support system (CDSS) to optimize cytotoxic drug dosing in cancer patients with renal insufficiency
2016 · L. Krens, M. Damhof · Annals of Oncology · 2
Use of risk medication for stomach ulcers and stomach protection relating to ulcer occurrence after bariatric surgery
2017 · B. Sezgi, M Damhof, et al. · University of Twente Research Information · 1
Early-onset hematological toxicity of docetaxel and survival in non-small cell lung cancer patients in the immune checkpoint inhibition era
2026 · M.P. Kicken, A.J. Grotenhuis, et al. · Cancer Treatment and Research Communications
THU0128 Do biological dmards prevent long term articular damage by rheumatoid arthritis in routine clinical care?
2018 · S. Baghban, L. Krens, et al. · Annals of the Rheumatic Diseases
PDF
Refining EGFR-monoclonal antibody treatment in colorectal cancer
2015 · Lisanne Krens · Leiden Repository (Leiden University)
PDF
Simvastatin Causes Translocation of Mutant K-ras in Colorectal Cancer Cells
2014 · Lisanne Krens, Candice Pullen, et al. · Data Archiving and Networked Services (DANS)
Abstract 1846: Co-treatment with simvastatin and cetuximab in KRAS mutant LoVo cells decreases PTK activity effectively and increases STK activity to overcome the anti-EGFR resistance
2014 · Lisanne Krens, Renee Pablo-Baak, et al. · Cancer Research
Simvastatin induces KRAS translocation in KRAS mutant colorectal cancer cells and may influence the susceptibility to anti-EGFR therapy
2013 · Lisanne Krens, Candice Pullen, et al. · Data Archiving and Networked Services (DANS)
Safety and efficacy of the addition of simvastatin to panitumumab in KRAS mutant metastatic colorectal cancer patients.
2013 · Henk-jan Guchelaar, Jara M Baas, et al. · Journal of Clinical Oncology
Safety and efficacy of the addition of simvastatin to cetuximab in KRAS mutant metastatic colorectal cancer patients.
2013 · Jara M Baas, Lisanne Krens, et al. · Journal of Clinical Oncology
Pharmacokinetics (PK) of panitumumab in a single patient with metastatic colorectal cancer (mCRC) and liver dysfunction.
2013 · Lisanne Krens, Jara Baas, et al. · Journal of Clinical Oncology
Works count: 25
Citation count: 383
H-index: 10
I10-index: 10
Year
Topic
Type